Early Functional Disability Predicts Both All-cause and Cardiovascular Mortality in People with Inflammatory Polyarthritis: Results from the Norfolk Arthritis Register

Overview

Journal Ann Rheum Dis

Specialty Rheumatology

Date 2006 Nov 9

PMID 17090565

Citations 26

Authors

Tracey M Farragher

Mark Lunt

Diane K Bunn

Alan J Silman

Deborah P M Symmons

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the predictive value of early functional disability in patients with inflammatory polyarthritis (IP), for all-cause and cardiovascular disease (CVD) mortality.

Methods: 1010 subjects with new-onset IP from the Norfolk Arthritis Register were studied. All were seen at baseline and at 1 year. Health Assessment Questionnaire (HAQ) scores were obtained at both time points. Vital status at 10 years from registration was established through central records. Mortality (all-cause and CVD) per 1000 person-years were calculated by HAQ stratum (HAQ scores<1, 1-2 and>or=2). The predictive value of HAQ (per unit increase) at the two time points, adjusted for age at onset of symptom, sex and other factors found to predict mortality, was assessed using Cox regression models. The analysis was repeated for those who satisfied the 1987 American College of Rheumatology criteria for rheumatoid arthritis (RA) by 5 years.

Results: By 10 years, 171 (16.9%) subjects had died. 89 deaths (52%) were attributed to CVD. Mortality was greatest in the highest HAQ group at both time points. Following adjustment for other predictors, HAQ score at year 1 remained a significant predictor of all-cause mortality (HR 1.46; 95% CI 1.15 to 1.85) and CVD mortality (HR 1.49; 95% CI 1.12 to 1.97). The predictive value of HAQ at year 1 was similar in the RA subgroup.

Conclusions: Our data show that at 1 year of follow-up, HAQ score is an important independent predictor of subsequent all-cause and CVD mortalities in people with IP and RA. Baseline HAQ scores are of less value.

Citing Articles

Association between functional dependence and cardiovascular disease among middle-aged and older adults: Findings from the China health and retirement longitudinal study.

Yang Y, Li C, Hong Y, Sun J, Chen G, Ji K Heliyon. 2024; 10(18):e37821.

PMID: 39315220 PMC: 11417238. DOI: 10.1016/j.heliyon.2024.e37821.

Trends in Activity Limitations From an International Perspective: Differential Changes Between Age Groups Across 30 Countries.

Beller J, Luy M, Giarelli G, Regidor E, Lostao L, Tetzlaff J J Aging Health. 2022; 35(7-8):477-499.

PMID: 36426682 PMC: 10302378. DOI: 10.1177/08982643221141123.

Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database.

Allanore Y, Bozzi S, Terlinden A, Huscher D, Amand C, Soubrane C Arthritis Res Ther. 2020; 22(1):257.

PMID: 33115544 PMC: 7592571. DOI: 10.1186/s13075-020-02329-2.

Can the adherence to quality of care indicators for early rheumatoid arthritis in clinical practice reduce risk of hospitalisation? Retrospective cohort study based on the Record Linkage of Rheumatic Disease study of the Italian Society for....

Zanetti A, Scire C, Argnani L, Carrara G, Zambon A BMJ Open. 2020; 10(9):e038295.

PMID: 32994247 PMC: 7526308. DOI: 10.1136/bmjopen-2020-038295.

Incident arterial vascular events in a cohort of Puerto Ricans with rheumatoid arthritis.

Gonzalez-Melendez A, Fred-Jimenez R, Arroyo-Avila M, Diaz-Correa L, Perez-Rios N, Rodriguez N SAGE Open Med. 2020; 8:2050312120958844.

PMID: 32974020 PMC: 7495931. DOI: 10.1177/2050312120958844.

References

Pincus T, Brooks R, Callahan L . Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures. Ann Intern Med. 1994; 120(1):26-34. DOI: 10.7326/0003-4819-120-1-199401010-00005. View

Leigh J, Fries J . Mortality predictors among 263 patients with rheumatoid arthritis. J Rheumatol. 1991; 18(9):1307-12. View

Symmons D, Barrett E, Bankhead C, SCOTT D, Silman A . The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol. 1994; 33(8):735-9. DOI: 10.1093/rheumatology/33.8.735. View

Coste J, Jougla E . Mortality from rheumatoid arthritis in France, 1970-1990. Int J Epidemiol. 1994; 23(3):545-52. DOI: 10.1093/ije/23.3.545. View

Silman A, Newman J, MacGregor A . Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins. Arthritis Rheum. 1996; 39(5):732-5. DOI: 10.1002/art.1780390504. View

Harrison B, Symmons D, Brennan P, Bankhead C, Barrett E, SCOTT D . Inflammatory polyarthritis in the community is not a benign disease: predicting functional disability one year after presentation. J Rheumatol. 1996; 23(8):1326-31. View

Wallberg-Jonsson S, Ohman M, Dahlqvist S . Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol. 1997; 24(3):445-51. View

Callahan L, Cordray D, Wells G, Pincus T . Formal education and five-year mortality in rheumatoid arthritis: mediation by helplessness scale score. Arthritis Care Res. 1996; 9(6):463-72. DOI: 10.1002/art.1790090608. View

Callahan L, Pincus T, Huston 3rd J, Brooks R, Nance Jr E, KAYE J . Measures of activity and damage in rheumatoid arthritis: depiction of changes and prediction of mortality over five years. Arthritis Care Res. 1998; 10(6):381-94. DOI: 10.1002/art.1790100606. View

10.

Symmons D, Jones M, Scott D, Prior P . Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. J Rheumatol. 1998; 25(6):1072-7. View

11.

Soderlin M, Nieminen P, Hakala M . Functional status predicts mortality in a community based rheumatoid arthritis population. J Rheumatol. 1998; 25(10):1895-9. View

12.

Harrison B, Symmons D, Barrett E, Silman A . The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. American Rheumatism Association. J Rheumatol. 1998; 25(12):2324-30. View

13.

Turesson C, Jacobsson L, Bergstrom U . Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford). 1999; 38(7):668-74. DOI: 10.1093/rheumatology/38.7.668. View

14.

Goodson N, Symmons D, Scott D, Bunn D, Lunt M, Silman A . Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort. Arthritis Rheum. 2005; 52(8):2293-9. DOI: 10.1002/art.21204. View

15.

Pollard L, Choy E, Scott D . The consequences of rheumatoid arthritis: quality of life measures in the individual patient. Clin Exp Rheumatol. 2005; 23(5 Suppl 39):S43-52. View

16.

Bruce B, Fries J . The Stanford Health Assessment Questionnaire: dimensions and practical applications. Health Qual Life Outcomes. 2003; 1:20. PMC: 165587. DOI: 10.1186/1477-7525-1-20. View

17.

Gabriel S, Crowson C, OFallon W . Mortality in rheumatoid arthritis: have we made an impact in 4 decades?. J Rheumatol. 1999; 26(12):2529-33. View

18.

Wallberg-Jonsson S, Johansson H, Ohman M, Rantapaa-Dahlqvist S . Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol. 1999; 26(12):2562-71. View

19.

Wiles N, Dunn G, Barrett E, Silman A, Symmons D . Associations between demographic and disease-related variables and disability over the first five years of inflammatory polyarthritis: a longitudinal analysis using generalized estimating equations. J Clin Epidemiol. 2000; 53(10):988-96. DOI: 10.1016/s0895-4356(00)00189-x. View

20.

Wiles N, Dunn G, Barrett E, Harrison B, Silman A, Symmons D . One year followup variables predict disability 5 years after presentation with inflammatory polyarthritis with greater accuracy than at baseline. J Rheumatol. 2000; 27(10):2360-6. View